Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*Sophie Georgin‐Lavialle, Thomas Cluzeau, Samuel Ardois et al.|British Journal of Dermatology|2021Cited by 414
Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficienciesAlain Fischer, Lionel Galicier, Johan Provot et al.|Journal of Allergy and Clinical Immunology|2017Cited by 316
HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndromeC. Belizna, Laurent Loufrani, Francesca Pregnolato et al.|Autoimmunity Reviews|2018Cited by 76
Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: A multicenter retrospective study of 59 casesÈve Zakine, C. Deligny, Loula Papageorgiou et al.|Journal of the American Academy of Dermatology|2022Cited by 67